Skip to content
naulon
Not checkedNot checked for notices yet.

Intralymphatic immunotherapy

Gabriela Senti, Thomas M Kündig

World Allergy Organization Journal · 2015

doi:10.1186/s40413-014-0047-7 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Gold Standard allergen-specific immunotherapy is associated with low efficacy because it requires either many subcutaneous injections of allergen or even more numerous sublingual allergen administrations to achieve amelioration of symptoms. Intralymphatic vaccination can maximize immunogenicity and hence efficacy. We and others have demonstrated that as few as three low dose intralymphatic allergen administrations are sufficient to effectively alleviate symptoms. Results of recent prospective and controlled trials suggest that this strategy may be an effective form of allergen immunotherapy. Keywords: Administration routes, Allergen immunotherapy, Intralympathic, Vaccination

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.